The specifications of the product correspond to the actual resin volume, with the resin content of 50%
This medicine has been associated with gastrointestinal side effects
For once-weekly injections, administer the missed dose as soon as possible if within the specified timeframe (e.g., within 5 days for semaglutide, at least 3 days before the next dose for dulaglutide)
In diabetes-related gastrointestinal complications Its metabolic regulatory properties could assist in improving abnormal gastrointestinal motility and dyspepsia, reducing symptoms such as nausea, vomiting, and constipation
In 1987, her paper with Habener and Daniel Drucker showed that GLP-1 stimulates glucose-dependent insulin secretion in the pancreas, suppresses glucagon release, and slows gastric emptying, all of which stabilize blood sugar levels after eating